Belpointe Asset Management’s AVEO Pharmaceuticals AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-1,000
Closed -$15K – 3931
2022
Q4
$15K Buy
+1,000
New +$13.8K ﹤0.01% 2399

Belpointe Asset Management's AVEO Position: Q1 2023 in Review

Belpointe Asset Management sold out of AVEO Pharmaceuticals (AVEO) in Q1 2023, closing a stake of 1,000 shares — an estimated $15K sold.

Belpointe Asset Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $15K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Belpointe Asset Management reported no remaining AVEO Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 1,000 AVEO Pharmaceuticals shares in Q1 2023, an estimated $15K.
  • Belpointe Asset Management first reported a position in AVEO Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • Belpointe Asset Management's AVEO Pharmaceuticals position peaked at $15K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals as of Q1 2023.

Based on Belpointe Asset Management's 13F filing for Q1 2023, filed 15 May 2023.